课题基金 / 基金详情

ESCAPE-MeVO trial (EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions)

ESCAPE-MeVO trial (EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions)
ESCAPE-MeVO 试验(腔内治疗可改善中型血管闭塞的结果)
批准号:
435558
负责人:
Goyal Mayank
金额:
$116.59万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-10-01 至 2023-10-01
关键词:

项目摘要

项目成果

Goyal Mayank的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The most common cause of stroke is when a clot blocks an artery that supplies blood to the brain. Every second lost in removing that clot results in more damage to the brain. There are two established treatments to remove the clot. A clot busting drug can
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cerebroprotection Trial Optimization in the Reperfusion Era: ESCAPE-CORE
  • 批准号:
    478543
  • 项目类别:
    Operating Grants
  • 资助金额:
    $130.46万
  • 财政年份:
    2023
  • 负责人:
    Goyal Mayank
  • 依托单位:
海外基金